Siga Technologies (SIGA) Cash from Investing Activities Growth (1y) (2011 - 2025)
Powered by 
Analysis
Siga Technologies (SIGA) Cash from Investing Activities Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 93.92% |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | -1.35% |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -627.53% |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -38.43% |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -46.70% |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -103.94% |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | -174.44% |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | 129.18% |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1,191.19% |
| Jun 30, 2025 | 99.95% |
| Jun 30, 2024 | 89.92% |
| Mar 31, 2021 | 11.46% |
| Mar 31, 2020 | -73.18% |
| Dec 31, 2019 | -100.00% |
| Jun 30, 2019 | 100.01% |
| Dec 31, 2018 | 170,677.62% |
| Jun 30, 2018 | 29.15% |
| Dec 31, 2017 | -103.82% |
| Sep 30, 2017 | -1,491,700.00% |
| Jun 30, 2017 | -1,458.70% |
| Dec 31, 2016 | 2,720.09% |
| Sep 30, 2016 | 100.00% |
| Mar 31, 2016 | -100.21% |
| Dec 31, 2015 | -2,027.65% |
| Sep 30, 2015 | 98.41% |
| Mar 31, 2015 | 28,300.79% |
| Dec 31, 2014 | 99.26% |
| Sep 30, 2014 | -1,794.05% |